Onset of action of formoterol/budesonide in single inhaler vs. formoterol in patients with COPD-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Onset of action of formoterol/budesonide in single inhaler vs. formoterol in patients with COPD

Published:2004-06 Issue:3 Volume:17 Page:121-125
ISSN:1094-5539
Container-title:Pulmonary Pharmacology & Therapeutics
language:en
Short-container-title:Pulmonary Pharmacology & Therapeutics

Author:

Cazzola M.,Santus P.,Di Marco F.,Carlucci P.,Mondoni M.,Matera M.G.,Centanni S.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biochemistry, medical,Pulmonary and Respiratory Medicine

Reference22 articles.

1. Onset of action of single doses of formoterol administered via Turbuhaler in patients with stable COPD;Cazzola;Pulm Pharmacol Ther,2001

2. Salmeterol and formoterol in partially reversible severe chronic obstructive pulmonary disease: a dose-response study;Cazzola;Respir Med,1995

3. Formoterol. A review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease;Faulds;Drugs,1991

4. Formoterol Turbuhaler for as-needed therapy in patients with mild acute exacerbations of COPD;Cazzola;Respir Med,2001

5. Long-acting β2 agonists as potential option in the treatment of acute exacerbations of COPD;Cazzola;Pulm Pharmacol Ther,2003

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacology and Therapeutics of Bronchodilators Revisited;Pharmacological Reviews;2019-12-17

2. Global initiative gold and national recommendations on the management of patients with chronic obstructive pulmonary disease (COPD): the place of double bronchodilation;Medical Council;2019-12-08

3. Benefit:Risk Profile of Budesonide in Obstructive Airways Disease;Drugs;2019-09-23

4. A potential role of triple therapy for asthma patients;Expert Review of Respiratory Medicine;2019-09-01

5. Bronchodilator Efficacy of a Single-Dose 12/400-µg Formoterol/Budesonide Combination as a Dry Powder for Inhalation Delivered by Discair® in Adult Patients with Moderate-to-Severe Stable COPD: Open-Label, Single-Arm, Phase IV Trial;Clinical Drug Investigation;2019-07-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3